Search

Strattera

Strattera

atomoxetine

Manufacturer:

Eli Lilly

Distributor:

Zuellig Pharma
Concise Prescribing Info
Contents
Atomoxetine HCl
Indications/Uses
ADHD in childn ≥6 yr, adolescents & adults.
Click to view Strattera detailed prescribing information
Dosage/Direction for Use
Adult, adolescent >70 kg & childn Initially 40 mg daily for at least 7 days. Maintenance: 80 mg daily. Max: 100 mg daily. Childn & adolescent up to 70 kg Initially 0.5 mg/kg daily for at least 7 days. Maintenance: 1.2 mg/kg daily. Max: 1.8 mg/kg daily.
Click to view Strattera detailed prescribing information
Overdosage
View Strattera overdosage for action to be taken in the event of an overdose.
Administration
May be taken with or without food: Swallow whole, do not open cap.
Contraindications
Hypersensitivity. Narrow-angle glaucoma. Severe CV or cerebrovascular disorders. History of pheochromocytoma. Concomitant use w/ MAOIs.
Click to view Strattera detailed prescribing information
Special Precautions
Discontinue use in patients w/ jaundice or lab evidence of liver injury; developing seizures. Suicide-related behaviour, preexisting cardiac abnormalities. HTN, tachycardia, severe CV or cerebrovascular disorders; congenital or acquired long QT or family history of QT prolongation; orthostatic hypotension; preexisting psychotic or manic symptoms eg, hallucinations, delusional thinking, mania or agitation; aggressive behaviour, hostility or emotional lability; allergic reactions. Monitor appearance or worsening of anxiety symptoms, depressed mood, depression or tics. Measure heart rate & BP before, during, after treatment & at least every 6 mth. Long-term treatment. May affect ability to drive & use machines. Moderate or severe hepatic insufficiency. Not to be used during pregnancy. Avoid use during lactation. Growth & development in childn & adolescents. Childn <6 yr.
Click to view Strattera detailed prescribing information
Adverse Reactions
Decreased appetite; insomnia; headache; dry mouth, nausea; increased BP & heart rate. Agitation, decreased libido, sleep disorder, depression & depressed mood, anxiety; dizziness, dysgeusia, paraesthesia, somnolence, tremor; palpitations, tachycardia; flushing, hot flush; abdominal pain, constipation, dyspepsia, flatulence, vomiting; dermatitis, hyperhydrosis, rash; dysuria, pollakuria, urinary hesitation & retention; dysmenorrhea, ejaculation disorder, erectile dysfunction, prostatitis, male genital pain; asthenia, fatigue, lethargy, chills, feeling jittery, irritability, thirst; decreased wt.
Click to view Strattera detailed prescribing information
Drug Interactions
MAOIs. Increased exposure w/ CYP2D6 inhibitors (fluoxetine, paroxetine) quinidine, terbinafine. Potentiation of CV effects w/ salbutamol or other β2-agonists. Increased risk of QT interval prolongation w/ other QT prolonging drugs eg, neuroleptics, class IA & III antiarrhythmics, moxifloxacin, erythromycin, methadone, mefloquine, TCAs, lithium or cisapride; thiazide diuretics; CYP2D6 inhibitors. Potential w/drawal seizures w/ benzodiazepines. Decreased effectiveness of antihypertensives or drugs used to treat HTN. Possible increased on BP w/ pressor agents. Additive or synergistic pharmacological effects by drugs that affect noradrenaline eg, imipramine, venlafaxine & mirtazapine, decongestants eg, pseudoephedrine or phenylephrine.
Click to view Strattera detailed prescribing information
Caution For Usage
For caution against possible variation of physical aspect of medicine... Click to view Strattera detailed prescribing information
Storage
View Strattera storage conditions for details to ensure optimal shelf-life.
Description
View Strattera description for details of the chemical structure and excipients (inactive components).
Action
View Strattera mechanism of action for pharmacodynamics and pharmacokinetics details.
MIMS Class
Other CNS Drugs & Agents for ADHD
ATC Classification
N06BA09 - atomoxetine ; Belongs to the class of centrally-acting sympathomimetics. Used as CNS stimulant.
Presentation/Packing
Form
Strattera cap 10 mg
Packing/Price
28's
Form
Strattera cap 18 mg
Packing/Price
28's
Form
Strattera cap 25 mg
Packing/Price
28's
Form
Strattera cap 40 mg
Packing/Price
28's
Form
Strattera cap 60 mg
Packing/Price
28's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in